DAIC

JUNE 11, 2024

Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. We are proud to lead the way in Italy, revolutionizing cardiac treatment through innovative robotic technology."

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

DAIC

JANUARY 8, 2024

milla1cf Mon, 01/08/2024 - 14:26 January 8, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC. Physicians at Vilnius University.

Ablation 111

Ablation Innovation Electrophysiology Technology 111

DAIC

JANUARY 31, 2024

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

HeartRhythm

NOVEMBER 7, 2024

Superior vena cava (SVC) conduction delay or isolation during right superior pulmonary vein (RSPV) ablation using thermal ablation technologies has been previously described.1,2 1,2 No reports regarding the impact of pulsed-field ablation (PFA) on the SVC exist.

Ablation 75

Ablation Pulmonary Technology 75

Medical Xpress - Cardiology

JULY 8, 2024

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.

Atrial Fibrillation 79

Atrial Fibrillation Ablation Technology 79

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

FEBRUARY 12, 2025

cardiac electrophysiologist, performed one of the nations first procedures to control atrial fibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. tim.hodson Wed, 02/12/2025 - 15:04 Feb.

AFIB 52

AFIB Research Ablation Atrial Fibrillation 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Introduction A new technology capable of monitoring local impedance (LI) and contact force (CF) has recently been developed. At the same time, there is growing concern regarding catheter ablation performed under fluoroscopy guidance, due to its harmful effects for both patients and practitioners. Ω vs. 31.2 ± 9.81 Ω, p  = 0.19).

Ablation 89

Ablation Technology 89

DAIC

OCTOBER 21, 2024

FDA approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance for the new FARAVIEW Software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation System.

Ablation 59

Ablation Atrial Fibrillation Technology Electrophysiology 59

HeartRhythm

APRIL 6, 2025

As cryoballoon technology continues to evolve, the introduction of lower-pressure and selectable-size balloons presents new considerations for both safety and efficacy of cryoablation of atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Best Practices Technology Ablation 40

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Circulation

JANUARY 6, 2025

BACKGROUND:Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high recurrence rates and long procedure durations. Predicted optimum ablation sites to terminate all VTs in the models were identified. Rapid-pacing protocols were used to induce VTs and to define the VT circuits.

Tachycardia 85

Tachycardia Ablation Technology Electrophysiology 85

Frontiers in Cardiovascular Medicine

MAY 1, 2024

BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Pulmonary Technology 52

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say 4.

Blood Pressure 105

Blood Pressure Angioplasty Heart attacks Heart Attack 105

HeartRhythm

MARCH 28, 2025

Rhythm control therapy and especially atrial fibrillation (AF) ablation are the focus of growing research in patients with AF. Recent findings suggest that reduction of AF burden mediates the beneficial effects of AF ablation on cardiovascular events and quality of life.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Technology 40

Journal of Cardiovascular Electrophysiology

AUGUST 26, 2024

Abstract Introduction Due to its unique features, pulsed field ablation (PFA) could potentially overcome some limitations of current radiofrequency (RF) ventricular tachycardia (VT) ablation. Methods Two patients with ischemic cardiomyopathy and previously failed RF VT ablations were treated with PFA.

Ablation 40

Ablation Tachycardia Cardiomyopathy Technology 40

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

HeartRhythm

APRIL 30, 2024

Pulsed Field Ablation (PFA) is a novel ablation technology that presents a safer and faster alternative to current ablation techniques. In theory, PFA can be fully incorporated into a mapping system, thus enabling patient specific targeted ablation in open heart procedures.

Ablation 40

Ablation Technology 40

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) catheter ablation trials report arrhythmia-free survival using different post-ablation rhythm monitoring protocols, resulting in difficulties in the interpretation of the recurrence rates and comparison of ablation strategies and technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Arrhythmia 40

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). iii] The study reported a low fluoroscopy time of 7.8

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

FEBRUARY 1, 2024

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System 3. Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

COVID-19 105

COVID-19 Heart Rhythm Technology Cardiovascular Disease 105

DAIC

JULY 17, 2024

The present invention relates to medical methods for transseptal access to the heart using steerable introducers based on the Company’s Morph DNA technology. This additional patent protection for BioCardia’s current and future products in this important existing market enhances shareholder value.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

Nature Reviews - Cardiology

JUNE 24, 2024

Nature Reviews Cardiology, Published online: 25 June 2024; doi:10.1038/s41569-024-01053-7 The advent of pulsed-field ablation — a series of ultra-rapid, high-energy pulses that result in non-thermal cell death via electroporation — is revolutionizing the field of atrial fibrillation ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

HeartRhythm

APRIL 30, 2024

Advancements in catheter design continue to improve safety during RF ablation. The TactiFlex™ Ablation Catheter, Sensor Enabled™ (TactiFlex SE) combines contact force sensing technology with a kerfed, flexible tip design.

Ablation 40

Ablation Technology 40

HeartRhythm

APRIL 30, 2024

The 1st generation HeartLight laser balloon (LB) ablation is highly effective in achieving pulmonary vein isolation (PVI), and the safety and 12-month efficacy are comparable with paroxysmal atrial fibrillation (PAF) ablation technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Journal of Cardiothoracic Surgery

JANUARY 22, 2025

Pulmonary vein isolation (PVI) with cryoballoon (CB) ablation technology is widely used to treat drug-resistant atrial fibrillation (AF). During CB ablation, there is a possibility of forming an ice cap of con.

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

SEPTEMBER 25, 2024

Pulsed field ablation (PFA)-induced electroporation is an application of high-energy, direct-current shocks on myocardium albeit at a considerably lower current density that decreases the risks of arcing and barotrauma.1

Ablation 40

Ablation Atrial Fibrillation Tachycardia Technology 40

Journal of Cardiovascular Electrophysiology

JANUARY 31, 2024

Abstract Introduction With the entry of pulsed-field ablation (PFA) into electrophysiology, new possibilities for ablation of different substrates such as epicardial foci of premature ventricular contractions (PVCs) from coronary venous system (CVS) have been opened.

Ablation 40

Ablation Electrophysiology Article Technology 40

AMS Cardiology

MARCH 31, 2025

Catheter Ablation: This minimally invasive procedure is now the gold standard for many AFib patients. Pulsed Field Ablation (PFA) : PFA uses controlled electrical fields to target abnormal heart tissue with a reduced risk of damaging surrounding structures like the esophagus or nerves. Other options are typically recommended first.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Heart Rhythm Blood Pressure 52

HeartRhythm

APRIL 30, 2024

Pulmonary vein (PV) isolation is the cornerstone of radiofrequency (RF) ablation for atrial fibrillation (AF). PV reconnection is the most common cause of recurrent AF following an ablation procedure. Advances in catheter technology, ablation techniques, and ablation lesion metrics have resulted in improved PV isolation durability.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

HeartRhythm

FEBRUARY 17, 2025

Electroanatomic mapping (EM) has revolutionized the understanding and ablation of complex arrhythmias by providing simultaneous representation of electrogram timing, location, and voltage in both space and time. In this editorial we will review mapping and ablation of APs, and it is divided into two parts.

Electrophysiology 40

Electrophysiology Ablation Laboratory Technology 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2023

This study investigated myocardial injury and inflammation following pulmonary vein isolation using (1) Standard radiofrequency ablation, (2) very high-power short-duration (vHPSD)-70W, (3) vHPSD-90W, and (4) pulsed-field ablation (PFA). Results Baseline characteristics were well-balanced between groups (age 63.1 ± 10.3 ng/L; p  < .001).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40